Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2011

01-06-2011 | Research Article

Exploring communications around medication review in community pharmacy

Authors: Susanne Kaae, Ellen Westh Sørensen, Lotte Stig Nørgaard

Published in: International Journal of Clinical Pharmacy | Issue 3/2011

Login to get access

Abstract

Objectives Investigation into aspects that influence outcomes of medication reviews have been called for. The aim of this study was to assess how pharmacy internship students in a Danish medication review and reconciliation model communicated with both diabetes patients and the patients’ General Practitioners (GPs) when conveying the results of the review by writing letters to the different parties. Special attention was drawn to how differences in health care provider and patient perspectives of the disease as well as inclusion of the patient in the decision making process is influenced by the identified practices of communication. Setting 18 Danish community pharmacies with The Department of Pharmacology and Pharmacotherapy at the Faculty of Pharmaceutical Sciences, University of Copenhagen. Method Number of identified drug related problems, life-world problems and solutions to these described in the letters sent to patients and their GPs were registered. Further a qualitative documentary analysis was conducted by analyzing the letters using the theory of transactional analysis, developed by Berne. Main outcome measures Identified and conveyed drug related and life-world related problems when comparing patients’ letters with GPs’ letters. Whether students assumed a superior, inferior or equal role in relation to the recipient of the letter and compared whether students assumed the same role in relation to patients and GPs. Results 18 pairs of patient and GP letters were analyzed. The analysis showed that students conveyed more drug-related problems to GPs than to patients. Furthermore, students assumed an equal relationship to GPs, whereas they frequently took superior positions when writing to patients. Students reported lifestyle problems both to GPs and to patients. Conclusion Pharmacy students in a Danish medication review and reconciliation model managed to detect and address lifestyle problems of patients to their GPs, thereby facilitating the merger of their professionaltechnical perspective with the life-world perspective of patients. However, patients were not encouraged to become more involved in the disease management process.
Literature
1.
go back to reference Krass I, Smith C. Impact of medication regimen reviews performed by community pharmacists for ambulatory patients through liaison with general practitioners. Int J Pharm Prac. 2000;8:111–20.CrossRef Krass I, Smith C. Impact of medication regimen reviews performed by community pharmacists for ambulatory patients through liaison with general practitioners. Int J Pharm Prac. 2000;8:111–20.CrossRef
2.
go back to reference Krass I, Taylor SJ, Smith C, Armour CL. Impact of medication use and adherence of Australian pharmacists’ diabetes care services. J Am Pharm Assoc (Wash). 2005;45:33–40. Krass I, Taylor SJ, Smith C, Armour CL. Impact of medication use and adherence of Australian pharmacists’ diabetes care services. J Am Pharm Assoc (Wash). 2005;45:33–40.
3.
go back to reference Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648–64.PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648–64.PubMedCrossRef
4.
go back to reference Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J. 2001;323:1–5.CrossRef Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J. 2001;323:1–5.CrossRef
5.
go back to reference Zermansky AG, Freemantle N. Is medication review by pharmacists of any use? Pharmacoeconomics. 2007;25(2):91–2.PubMedCrossRef Zermansky AG, Freemantle N. Is medication review by pharmacists of any use? Pharmacoeconomics. 2007;25(2):91–2.PubMedCrossRef
6.
go back to reference Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists’ diabetes care service. J Am Pharm Assoc (Wash). 2004;44:455–66. Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists’ diabetes care service. J Am Pharm Assoc (Wash). 2004;44:455–66.
7.
go back to reference Cranor CL, Christensen DB. The Asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):149–59.CrossRef Cranor CL, Christensen DB. The Asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):149–59.CrossRef
8.
go back to reference Cranor CL, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173–84.CrossRef Cranor CL, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173–84.CrossRef
9.
go back to reference Wermeille J, Bennie M, Brown I, McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci. 2004;26:18–25.PubMedCrossRef Wermeille J, Bennie M, Brown I, McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci. 2004;26:18–25.PubMedCrossRef
10.
go back to reference Chen TF, de Almeida Neto AC. Exploring elements of interprofessional collaboration between pharmacists and phycisians in medication review. Pharm World Sci. 2007;29:574–6.PubMedCrossRef Chen TF, de Almeida Neto AC. Exploring elements of interprofessional collaboration between pharmacists and phycisians in medication review. Pharm World Sci. 2007;29:574–6.PubMedCrossRef
11.
go back to reference Loewe R, Freeman J. Interpreting diabetes mellitus: differences between patient and provider models of disease and their implications for clinical practice. Cult Med Psychiatry. 2000;24:379–401.PubMedCrossRef Loewe R, Freeman J. Interpreting diabetes mellitus: differences between patient and provider models of disease and their implications for clinical practice. Cult Med Psychiatry. 2000;24:379–401.PubMedCrossRef
12.
go back to reference Hunt LM, Arar NH. An analytical framework for contrasting patient and provider views of the process of chronic disease management. Med Anthropol Q. 2001;15(3):347–67.PubMedCrossRef Hunt LM, Arar NH. An analytical framework for contrasting patient and provider views of the process of chronic disease management. Med Anthropol Q. 2001;15(3):347–67.PubMedCrossRef
13.
go back to reference Wiuff MB, Jacobsen CB, Sørensen TH, Nielsen ML. Intensiv polyfarmakologisk behandling af patienter med type 2-diabetes i daglig klinisk praksis. København: Sundhedsstyrelsen, Enhed for Medicinsk Teknologivurdering; 2007. Wiuff MB, Jacobsen CB, Sørensen TH, Nielsen ML. Intensiv polyfarmakologisk behandling af patienter med type 2-diabetes i daglig klinisk praksis. København: Sundhedsstyrelsen, Enhed for Medicinsk Teknologivurdering; 2007.
14.
go back to reference Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication: participatory decision making, and the patient understanding in diabetes self-management. J Gen Intern Med. 2002;17:243–52.PubMedCrossRef Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication: participatory decision making, and the patient understanding in diabetes self-management. J Gen Intern Med. 2002;17:243–52.PubMedCrossRef
15.
go back to reference Jahng KH, Martin LR, Golin CE, DiMatteo R. Preferences for medical collaboration: patient-physician congruence and patient outcomes. Patient Educ Couns. 2005;57:308–14.PubMedCrossRef Jahng KH, Martin LR, Golin CE, DiMatteo R. Preferences for medical collaboration: patient-physician congruence and patient outcomes. Patient Educ Couns. 2005;57:308–14.PubMedCrossRef
16.
go back to reference Roach P, Marrero D. A critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk. Vasc Health Risk Manag. 2005;1(4):301–7.PubMedCrossRef Roach P, Marrero D. A critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk. Vasc Health Risk Manag. 2005;1(4):301–7.PubMedCrossRef
17.
go back to reference Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7:235–45.PubMedCrossRef Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7:235–45.PubMedCrossRef
18.
go back to reference Haidet P, Kroll TL, Sharf BF. The complexity of patient participation: lessons learned from patients’ illness narratives. Patient Educ Couns. 2006;62:323–9.PubMedCrossRef Haidet P, Kroll TL, Sharf BF. The complexity of patient participation: lessons learned from patients’ illness narratives. Patient Educ Couns. 2006;62:323–9.PubMedCrossRef
19.
go back to reference Golin CE, DiMatteo MR, Leaks B, Duan N, Gelberg L. A diabetes-specific measure of patient desire to participate in medical decision making. Diabetes Educ. 2001;27(6):875–86.PubMedCrossRef Golin CE, DiMatteo MR, Leaks B, Duan N, Gelberg L. A diabetes-specific measure of patient desire to participate in medical decision making. Diabetes Educ. 2001;27(6):875–86.PubMedCrossRef
20.
go back to reference Golin CE, DiMatteo MR, Duan N, Leaks B, Gelberg L. Impoverished diabetic patients whose doctors facilitate their participation in medical decision making are more satisfied with their care. J Gen Intern Med. 2002;17:866–75.CrossRef Golin CE, DiMatteo MR, Duan N, Leaks B, Gelberg L. Impoverished diabetic patients whose doctors facilitate their participation in medical decision making are more satisfied with their care. J Gen Intern Med. 2002;17:866–75.CrossRef
21.
go back to reference Doucette WR, Nevins J, McDonough RP. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm. 2005;1:565–78.PubMed Doucette WR, Nevins J, McDonough RP. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm. 2005;1:565–78.PubMed
22.
go back to reference Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004;38:764–70.PubMedCrossRef Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004;38:764–70.PubMedCrossRef
23.
go back to reference McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc (Wash). 2001;41(5):682–92. McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc (Wash). 2001;41(5):682–92.
24.
go back to reference Thornquist E. Klinik, kommunikation, information [Clinic, communication, information]. Copenhagen: Hans Reitzels Forlag a/s; 2000. Thornquist E. Klinik, kommunikation, information [Clinic, communication, information]. Copenhagen: Hans Reitzels Forlag a/s; 2000.
25.
go back to reference Chen TF, Moles R, Nishtala P, Basger B. Case studies in practice. Medication review: a process guide for pharmacists. 2nd ed. Pharmaceutical Society of Australia 2010; ISBN: 978-0-646-52420-7. Chen TF, Moles R, Nishtala P, Basger B. Case studies in practice. Medication review: a process guide for pharmacists. 2nd ed. Pharmaceutical Society of Australia 2010; ISBN: 978-0-646-52420-7.
26.
go back to reference Berne E. Intuition and ego states. 1st ed. San Fransisco: TA Press; 1977. ISBN: 0-89489-001-8. Berne E. Intuition and ego states. 1st ed. San Fransisco: TA Press; 1977. ISBN: 0-89489-001-8.
27.
go back to reference Lützen P. Sproglig analyse og relevans [Linguistic analysis and relevance]. 1st ed. Dansklærerforeningen; 2004 ISBN: 87-7996-025-1. Lützen P. Sproglig analyse og relevans [Linguistic analysis and relevance]. 1st ed. Dansklærerforeningen; 2004 ISBN: 87-7996-025-1.
28.
go back to reference Lauvås K, Lauvås P. Tværfagligt samarbejde: perspectiv og strategi [Professional collaboration: perspective and strategy]. Århus: Klim; 2006. ISBN: 87-7955-463-6. Lauvås K, Lauvås P. Tværfagligt samarbejde: perspectiv og strategi [Professional collaboration: perspective and strategy]. Århus: Klim; 2006. ISBN: 87-7955-463-6.
29.
go back to reference Vinter-Repalust N, Petricek G, Katic M. Obstacles which patients with type 2 diabetes meet adhering to the therapeutic regimen in everyday life: qualitative study. Croat Med J. 2004;45(5):630–6.PubMed Vinter-Repalust N, Petricek G, Katic M. Obstacles which patients with type 2 diabetes meet adhering to the therapeutic regimen in everyday life: qualitative study. Croat Med J. 2004;45(5):630–6.PubMed
30.
go back to reference Kumagai AK, Murphy EA, Ross PT. Diabetes stories: use of patient narratives of diabetes to teach patient-centered care. Adv Health Sci Educ Theory Pract. 2008;14:315–26.PubMedCrossRef Kumagai AK, Murphy EA, Ross PT. Diabetes stories: use of patient narratives of diabetes to teach patient-centered care. Adv Health Sci Educ Theory Pract. 2008;14:315–26.PubMedCrossRef
31.
go back to reference Fhärm E, Rolandsson O, Johansson EE. Aiming for the stars’—GPs’ dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus groups interviews. Fam Pract. 2009;26:109–14.PubMedCrossRef Fhärm E, Rolandsson O, Johansson EE. Aiming for the stars’—GPs’ dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus groups interviews. Fam Pract. 2009;26:109–14.PubMedCrossRef
32.
go back to reference Wens J, Vermeire E, Royen PV, Sabbe B, Denekens J. GPs’ perspectives of type 2 diabetes patients’ adherence to treatment: a qualitative analysis of barriers and solutions. BMC Family Practice. 2005;6(20). Wens J, Vermeire E, Royen PV, Sabbe B, Denekens J. GPs’ perspectives of type 2 diabetes patients’ adherence to treatment: a qualitative analysis of barriers and solutions. BMC Family Practice. 2005;6(20).
33.
go back to reference Cooper RJ, Bissell P, Wingfield J. ‘Islands and doctor’s tool’: the ethical significance of isolation and subordination in UK community pharmacy. Health (NY). 2009;13:297–316.CrossRef Cooper RJ, Bissell P, Wingfield J. ‘Islands and doctor’s tool’: the ethical significance of isolation and subordination in UK community pharmacy. Health (NY). 2009;13:297–316.CrossRef
Metadata
Title
Exploring communications around medication review in community pharmacy
Authors
Susanne Kaae
Ellen Westh Sørensen
Lotte Stig Nørgaard
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9502-5

Other articles of this Issue 3/2011

International Journal of Clinical Pharmacy 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine